NCT04899050View on ClinicalTrials.gov

Epidiolex in Typical Absence Seizures

PHASE4CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

May 27, 2023

Study Completion Date

May 27, 2023

Conditions

Study the Efficacy of Epidiolex for Typical Absence Seizures

Interventions

DRUG

Cannabidiol (Epidiolex)

Use of Epidiolex to control absence seizures.

Trial Locations (1)

33606

University of South Florida, Tampa

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

University of South Florida

OTHER